LGLAX | VIGAX | LGLAX / VIGAX | |
Total Expense Ratio | 0.90 | 0.05 | 1,800% |
Annual Report Gross Expense Ratio | 0.90 | 0.05 | 1,800% |
Fund Existence | 14 years | 25 years | - |
Gain YTD | 7.218 | 6.330 | 114% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1500 | 3000 | 50% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.36B | 294B | 3% |
Annual Yield % from dividends | 0.00 | 0.46 | - |
Returns for 1 year | 24.23 | 15.68 | 155% |
Returns for 3 years | 86.97 | 93.72 | 93% |
Returns for 5 years | 43.97 | 122.85 | 36% |
Returns for 10 years | 116.27 | 309.30 | 38% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RNPFX | 69.55 | 0.46 | +0.67% |
American Funds New Perspective R5 | |||
HAOYX | 22.77 | 0.11 | +0.49% |
Hartford International Opportunities Y | |||
SIIEX | 17.76 | 0.08 | +0.45% |
Touchstone International Value Y | |||
GLRBX | 22.94 | 0.04 | +0.19% |
James Balanced: Golden Rainbow R | |||
ETIHX | 34.10 | -0.05 | -0.15% |
Eventide Healthcare & Life Sciences I |